CHICAGO, IL / ACCESSWIRE / September 22, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
The All Cosmos Bio-Tech EPS (TTM) is 2.04. All Cosmos Bio-Tech (4148) reported sales of 829.80, net income of 68.76, and EPS of 1.02 for the latest quarter. What was All Cosmos Bio-Tech's net income ...
ZURICH, ZURICH, SWITZERLAND, August 2, 2023/EINPresswire.com/ -- InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s ...
Click the link below to download a spreadsheet with an example Market Cap calculation for All Cosmos Bio-Tech Holding Corp below: The chart above depicts the distribution of Market Cap for companies ...
Explore the TYO:3386 financials. Find the Cosmo Bio financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial ...
Bio-Quant’s parent, NexMed, claims deal will provide formal presence in Japan and increase existing foothold. Japanese company Cosmo Bio negotiated distribution rights to Bio-Quant’s discovery and ...
In addition, Enzo will make Cosmo Bio’s extensive catalog of Japanese manufactured research biotools, for which it is a leading distributor, available to researchers around the world through Enzo’s ...
DiscoveRx Corporation announces the selection of Cosmo Bio Co., Ltd. as a key distributor for the Japanese territory. “Cosmo Bio's leadership in providing third party drug discovery services to the ...
About All Cosmos Bio-Tech Holding Corp. All Cosmos Bio-Tech Holding Corp. engages in the manufacture, distribute, research and development of bio-organic and bio-chemical fertilizers. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results